The controversy over a cartoon in an NCERT textbook sends a chill down the spine as it shows the extent to which the culture of intolerance has eaten into the vitals of our democratic polity. The cartoon in question shows B R Ambedkar sitting on a snail (Constitution) and flogging it while Jawaharlal Nehru too is brandishing a whip standing behind Ambedkar. It is clear that he is also aiming his...

A scholarly study of corruption in the larger context of societal growth and development Corruption is no longer a word and has become a noise. Debates on corruption have reached high decibel levels and the world is no closer to solutions. Given the complexity, there are as many views as there are participants. Some speak from high moral pedestals like those from the rich, donor countries. It is no surprise that...

The proposed criminalisation of consensual sex between youngsters in the 16-18 age group is seen as regressive and in denial of social realities. THE minimum age for consensual sex has been raised from 16 to 18 in the amended Protection of Children from Sexual Offences Bill, 2011, recently approved by the Union Cabinet. If approved by Parliament, this will make sexual activity with a person below 18 a criminal offence,...

Veteran agricultural scientist and alumnus of Harvard and Berkeley Universities, Dr Peter Kenmore was in Mumbai for NABARD’s 30th anniversary lecture on ‘Future of Global Agriculture: Challenges and Opportunities for India.’ This United Nations Food & Agriculture Organization India representative spoke to Yogesh Pawar on the current scenario in agriculture. Some excerpts: There’s a lot of churn over GM technology in India. At a time when the country is grappling with...

Health activists and cancer patients in the US have pounced on Swiss drug multinational Novartis for the high price of its famous, multi-billion dollar anti-cancer drug Glivec, a development which challenges pharma MNCs' claims of cheap access and affordability for patented drugs. Such protests, which began first in Europe, and have now spread to the US, could make it more difficult for pharma MNCs in developing countries to convince sceptical governments...